Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Global Medical Case Management Market - 2025-2033
... period 2025-2033. The global medical case management market is growing due to chronic diseases, rising healthcare costs, and the demand for personalized patient care. Digital health technologies like telehealth and electronic health records are improving ... Read More
-
Global Non-invasive Glucose Monitoring Devices Market 2025-2029
... the non-invasive glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Insulin Pumps Market - Focused Insights 2021-2030
... global market share, making it the largest category within the global insulin pump market. By Indication Type: The type 1 segment is expected to grow at the fastest CAGR of 9.31%, contributing significantly to the ... Read More
-
Insulin Pumps
... CAGR of 7.0% over the analysis period 2024-2030. Tethered Pumps, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$15.0 Billion by the end of the analysis ... Read More
-
Diabetes Drugs
... CAGR of 9.3% over the analysis period 2024-2030. Oral, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$163.4 Billion by the end of the analysis period. ... Read More
-
Injection Pens
... CAGR of 5.9% over the analysis period 2024-2030. Disposable, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the analysis period. ... Read More
-
Diabetic Food
... CAGR of 4.8% over the analysis period 2024-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. Growth ... Read More
-
Diabetic Macular Edema Treatment
... 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Anti-VEGF, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$2.7 Billion by the end ... Read More
-
Diabetic Nephropathy Treatment
... at a CAGR of 4.8% over the analysis period 2024-2030. Angiotensin Receptor Blockers (ARBs), one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Rare Endocrine Disease Treatment
... 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Acromegaly, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.7 Billion by the end ... Read More
-
Continuous Glucose Monitoring Systems
... 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Sensors, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.4 Billion by the end ... Read More
-
Diabetic Shoes
... CAGR of 8.1% over the analysis period 2024-2030. Online, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.6 Billion by the end of the analysis period. ... Read More
-
Diabetes Injection Pens
... at a CAGR of 5.7% over the analysis period 2024-2030. Insulin Pens, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$8.2 Billion by the end of ... Read More
-
Metabolic Health
... cutting-edge products designed to optimize energy levels and support a healthier lifestyle. It will include expert insights on how diet, exercise, and sleep impact metabolic health to the newest research on food supplements and interventions. Read More
-
Artificial Pancreas Device Systems
... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More
-
Insulin Pen Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Standard Insulin Pen Needles, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the ... Read More
-
Nocturia Drugs
... CAGR of 6.1% over the analysis period 2024-2030. Low Nocturnal Bladder Capacity, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Diabetic Foot Ulcers and Pressure Ulcers
... reach US$6.0 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Diabetic Foot Ulcers, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and ... Read More
-
Clinical Nutrition For Diabetes Care Market Size, Share & Trends Analysis Report By Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), By Stage, By Sales Channel, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... the forecast period from 2024 to 2033. Key Takeaways: North America clinical nutrition for diabetes care market accounted for a share of 33.48% in 2023. The U.S. clinical nutrition market for diabetes care dominated the ... Read More
-
Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030
... the increasing rise of diabetic patients, rising cases of traumatic injuries and burn injuries, and the growing geriatric population, which drives market growth. Additionally, rising usage of simplified single-use devices is expected to impact market ... Read More
-
Global Clinical Nutrition For Diabetes Care Market Size study, by Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, and Regional Forecasts 2022-2032
... 2024-2032. In a world where lifestyle disorders continue to dominate public health discourse, the burden of diabetes—particularly Type 2 diabetes—has rapidly expanded into a full-blown global crisis. Within this context, clinical nutrition has emerged not ... Read More
-
China Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... has witnessed a significant rise in the prevalence of diabetes in recent decades, posing a major public health challenge for the nation. This surge in diabetes cases can be primarily attributed to factors such as ... Read More
-
Enteral Feeding Devices Market by Type (Feeding Tubes (NG, NJ, OG, Gastronomy), Pumps: Feeding, Syringes; Consumables), Age (Neonates, Pediatric, Adult), Application (Oncology, GIT, Neuro, Diabetes), End User (Hospitals, Home, ASC) - Global Forecast to 2030
... enteral feeding systems safer, more effective, and easier for caregivers and family members to manage. Rigorous specifications from healthcare authorities ensure that these systems meet high standards of safety and efficiency. Other factors contributing to ... Read More
-
Healthcare And Consumer Care Ayurveda Products Market Research Report Information, By Product (Tablets And Capsules, Soaps And Shampoo, Body Wash, Moisturizers & Lotion, Oil, Facewash, Toothwash/Mouthwash, Creams & Serums, Aftershaves & Shaving Creams, Face Mask & Hair Mask, Dental Floss, Syrups, Powders, And Others), By Type (Supplements, Personal Care (Tablets And Capsules, Soaps And Shampoo, Body Wash, Moisturizers & Lotion, Oil, Facewash, Toothwash/Mouthwash, Creams & Serums, Aftershaves & Shaving Creams, Face Mask & Hair Mask, Dental Floss)), By Route Of Administration (Oral And Topical), By Application (Healthcare (Diabetes, Pregnancy And Postpartum Care, Respiratory Disorder, Cardiovascular Diseases, Eye Health, Gut And Digestive Health, And Others), Consumer Care (Skin Care, Hair Care, Oral Care, Baby Care, And Others)), By Age Group (Pediatrics, Adult, And Geriatrics), and By Distribution Channel (Online, Offline (Retail Pharmacies, Supermarkets & Hypermarkets, And Others) Ind
... use of ayurvedic products around the world. Furthermore, the rising global campaign is driving market expansion. For example, in August 2025, Maharishi Ayurveda created an entertaining oral care commercial called #RightYourWrongs, which included National Award-winning ... Read More
Research Assistance
